INDOCO REMEDIES LIMITED

Location

Maharashtra

Founded

1947-08-23

Risk Signals

86 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about INDOCO REMEDIES LIMITED

Live alerts from global media, monitored by Business Radar

Indoco Remedies receives USFDA final approval for Allopurinol Tablets |  News

2025-05-23 (capitalmarket.com)

Indoco Remedies receives USFDA final approval for Allopurinol Tablets | News

Indoco Remedies announced final approval of Allopurinol Tablets USP, 200 mg through Company's Abbreviated New Drug Application (ANDA) for Allopu...

Read more
Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood

2025-05-23 (medicaldialogues.in)

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood

Mumbai: Indoco Remedies Ltd. has announced the final approval of Allopurinol Tablets USP 200 mg through its Abbreviated New Drug Application (ANDA) for Allopurinol Tablets USP to market a generic...

Read more
Indoco Remedies receives U.S. FDA approval for generic Cetirizine tablets

2024-10-04 (expresspharma.in)

Indoco Remedies receives U.S. FDA approval for generic Cetirizine tablets

Indoco Remedies secures final approval from the U.S. FDA for its generic version of Zyrtec Allergy Tablets

Read more
Indoco Remedies and Concept Communication launches campaign for Sensodent K, Pata hai Kyun? - Brand Wagon News | The Financial Express

2024-01-15 (financialexpress.com)

Indoco Remedies and Concept Communication launches campaign for Sensodent K, Pata hai Kyun? - Brand Wagon News | The Financial Express

The campaign introduces a fictional world named the 'Mangalverse', illustrating characters' lives, eccentricities, and quirks

Read more
FDA approves Indoco Remedies, Lacosamide injection - ET HealthWorld | Pharma

(indiatimes.com)

FDA approves Indoco Remedies, Lacosamide injection - ET HealthWorld | Pharma

Indoco Remedies: Lacosamide injection is indicated for the prevention and control of seizures.

Read more
Indoco Remedies gets USFDA okay for Pregabalin capsules

(medicaldialogues.in)

Indoco Remedies gets USFDA okay for Pregabalin capsules

Pregabalin is used for Neuropathic pain associated with diabetic peripheral neuropathy and spinal cord injury, Postherpetic neuralgia and Fibromyalgia.

Read more
Indoco Remedies receives final ANDA approval from the USFDA for Cetirizine Hydrochloride Tablets

(indianpharmapost.com)

Indoco Remedies receives final ANDA approval from the USFDA for Cetirizine Hydrochloride Tablets

Cetirizine is used for relief of symptoms of hay fever and other allergic conditions

Read more
Indoco Remedies launches Brinzolamide Ophthalmic Suspension 1% in US

(medicaldialogues.in)

Indoco Remedies launches Brinzolamide Ophthalmic Suspension 1% in US

Mumbai: Indoco Remedies has recently announced the launch of Brinzolamide Ophthalmic Suspension 1% in the United States, the first generic version of AZOPT by Teva Pharmaceuticals. The product is...

Read more
Indoco Remedies gets USFDA nod for Cetirizine tablets, shares surge 3% - CNBC TV18

(cnbctv18.com)

Indoco Remedies gets USFDA nod for Cetirizine tablets, shares surge 3% - CNBC TV18

Indoco Remedies secures USFDA approval for Cetirizine Tablets, marking another milestone in its OTC portfolio. Shares surge over 3%, while the company plans its US launch of Lofexidine Tablets soon

Read more
Teva launches Indoco Remedies-developed generic drug in US -

(economictimes.com)

Teva launches Indoco Remedies-developed generic drug in US -

​​The product, which is a generic version of Azopt ophthalmic suspension, is developed and manufactured by the Mumbai-based drug firm at its Goa facility for Teva.

Read more

Never miss a headline about INDOCO REMEDIES LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages